Amir Reza Moravejolahkami
Overview
Explore the profile of Amir Reza Moravejolahkami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moravejolahkami A, Shakibaei M, Sharma M, Mohammadnezhad M, Devarakonda S
Heliyon
. 2024 Sep;
10(18):e37705.
PMID: 39323842
Background: Recent studies imply that Mediterranean Diet (MeD) may play an important role in the management of Multiple Sclerosis (MS). This meta-analysis aimed to evaluate the effectiveness of MeD in...
2.
Brockmueller A, Buhrmann C, Moravejolahkami A, Shakibaei M
J Adv Res
. 2024 Jan;
66:181-195.
PMID: 38190940
Background: Colorectal cancer (CRC), which is mainly caused by epigenetic and lifestyle factors, is very often associated with functional plasticity during its development. In addition, the malignant plasticity of CRC...
3.
Moravejolahkami A, Chitsaz A, Hassanzadeh A, Paknahad Z
Complement Ther Clin Pract
. 2023 Aug;
53:101794.
PMID: 37651846
Background And Purpose: There is growing evidence that dietary modification can improve clinical manifestations in multiple sclerosis (MS) patients. This study aimed to assess the impact of synbiotics and anti-inflammatory-antioxidant-rich...
4.
Moravejolahkami A, Hadi S, Hadi V, Mirghazanfari S, Mohajeri M
J Integr Complement Med
. 2023 Jun;
29(11):747-756.
PMID: 37307014
To evaluate the efficacy of dietary modifications based on complementary and alternative Iranian medicine (CAIM) in patients with secondary-progressive multiple sclerosis (SPMS). In this randomized controlled trial, 70 SPMS patients...
5.
Moravejolahkami A, Shakibaei M, Fairley A, Sharma M
Diabetes Metab Res Rev
. 2023 May;
40(2):e3655.
PMID: 37183580
Dysbiosis or imbalance of microbes in the gut has been associated with susceptibility and progression of type 1 diabetes mellitus (T1DM). The present systematic review and meta-analysis examined the effects...
6.
Iraj B, Moravejolahkami A, Sami R, Riahinezhad M, Tasdighi Z, Toghyani A, et al.
J Res Med Sci
. 2023 Apr;
28:15.
PMID: 37064792
Background: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEinhs) may deteriorate or improve the clinical manifestations in severe acute respiratory syndrome coronavirus 2 infection. A comparative, cross-sectional study...
7.
Moravejolahkami A, Chitsaz A, Hassanzadeh A, Paknahad Z
Nutr Neurosci
. 2022 Sep;
26(11):1078-1089.
PMID: 36173031
Background: Current evidence has demonstrated that patients with Multiple Sclerosis (MS) have dysbiotic gut microbiomes, and anti-inflammatory nutritional interventions can normalize this status. Therefore, we aimed to investigate the effects...
8.
Mirashrafi S, Moravejolahkami A, Balouch Zehi Z, Kermani M, Bahreini-Esfahani N, Haratian M, et al.
Clin Nutr ESPEN
. 2021 Dec;
46:1-8.
PMID: 34857182
Background & Aims: There are some studies indicating the effects of probiotic-containing foods or supplements on viral diseases. We aimed to conduct a rapid review of probiotics with specific emphasis...
9.
Bohlouli J, Namjoo I, Borzoo-Isfahani M, Poorbaferani F, Moravejolahkami A, Clark C, et al.
Br J Nutr
. 2021 Aug;
128(7):1274-1284.
PMID: 34392854
Background: Current evidence suggests that adherence to the Mediterranean diet (MeD) can reduce inflammation in chronic diseases; however, studies pertaining to relapsing-remitting multiple sclerosis (RRMS) are limited. Therefore, the aim...
10.
Mirashrafi S, Hejazi Taghanaki S, Sarlak F, Moravejolahkami A, Kermani M, Haratian M
Int J Clin Pract
. 2021 Aug;
75(11):e14724.
PMID: 34379879
Background: Probiotics may have a promising role in chronic autoinflammatory diseases. The current systematic review and meta-analysis investigated the effects of probiotics on disease progression, depression, general health, and anthropometric...